Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

ICI 89406

Copy Product Info
🥰Excellent
Catalog No. T22852Cas No. 53671-71-9
Alias 1-[2-[[3-(2-cyanophenoxy)-2-hydroxypropyl]amino]ethyl]-3-phenylurea

ICI 89406 (1-[2-[[3-(2-cyanophenoxy)-2-hydroxypropyl]amino]ethyl]-3-phenylurea) is a β-adrenergic antagonist.

ICI 89406

ICI 89406

Copy Product Info
🥰Excellent
Purity: 99.92%
Catalog No. T22852Alias 1-[2-[[3-(2-cyanophenoxy)-2-hydroxypropyl]amino]ethyl]-3-phenylureaCas No. 53671-71-9
ICI 89406 (1-[2-[[3-(2-cyanophenoxy)-2-hydroxypropyl]amino]ethyl]-3-phenylurea) is a β-adrenergic antagonist.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$66In StockIn Stock
5 mg$148In StockIn Stock
10 mg$212In StockIn Stock
25 mg$398In StockIn Stock
50 mg$583In StockIn Stock
1 mL x 10 mM (in DMSO)$156In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.92%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

ICI 89406 AI Summary
ICI 89406 exhibits a broad spectrum of bioactivities, demonstrating notable antiviral, enzymatic, and cellular effects. It shows antiviral activity against SARS-CoV-2 by inhibiting virus-induced cytotoxicity in both Caco-2 and VERO-6 cells, with inhibition rates of -4.03% and -0.22% at a concentration of 10 µM after 48 hours, respectively. Additionally, it inhibits SARS-CoV-2 3CL-Pro protease by 30.65% at 20 µM. In enzyme assays, ICI 89406 inhibits human HDAC6 by 21.84% using a commercial peptide and 5.33% with a custom peptide substrate. Its impact on protein thermal stability varies, causing both stabilization and destabilization across different domains. The compound also shows complexity in GPCR beta-arrestin recruitment assays, affecting targets such as GPR119, APLNR, ADGRF1, ADRB2, FFAR4, GPR35, C5AR1, and S1PR1 with both inhibitory and stimulatory actions. Moreover, it displays cell-type dependent bioactivity in viability assays, promoting moderate growth in HEK293T cells but not significantly affecting U2OS cells or human fibroblasts. These diverse activities underscore the potential of ICI 89406 for further research across various biological pathways and disease models..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
ICI 89406 (1-[2-[[3-(2-cyanophenoxy)-2-hydroxypropyl]amino]ethyl]-3-phenylurea) is a β-adrenergic antagonist.
Synonyms1-[2-[[3-(2-cyanophenoxy)-2-hydroxypropyl]amino]ethyl]-3-phenylurea
Chemical Properties
Molecular Weight354.4
FormulaC19H22N4O3
Cas No.53671-71-9
SmilesOC(CNCCNC(=O)Nc1ccccc1)COc1ccccc1C#N
Relative Density.1.25 g/cm3 (Predicted)
Storage & Solubility Information
StorageIn solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
Ethanol: Soluble
DMSO: 250 mg/mL (705.42 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.8217 mL14.1084 mL28.2167 mL141.0835 mL
5 mM0.5643 mL2.8217 mL5.6433 mL28.2167 mL
10 mM0.2822 mL1.4108 mL2.8217 mL14.1084 mL
20 mM0.1411 mL0.7054 mL1.4108 mL7.0542 mL
50 mM0.0564 mL0.2822 mL0.5643 mL2.8217 mL
100 mM0.0282 mL0.1411 mL0.2822 mL1.4108 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy ICI 89406 | purchase ICI 89406 | ICI 89406 cost | order ICI 89406 | ICI 89406 chemical structure | ICI 89406 formula | ICI 89406 molecular weight